FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Intelligent Bio Solutions Inc. Stock AnalysisComprehensive stock analysis for Intelligent Bio Solutions Inc. (INBS) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisINBS
INBS
Intelligent Bio Solutions Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
INBS
Home🔹Stocks🔹Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc.

INBS•NASDAQ

Intelligent Bio Solutions Inc.

INBS•NASDAQ
Market cap
$1.03M
Sentiment

Your view on INBS

Mkt Cap
$1.03M
Sentiment
Your view
INBS
Intelligent Bio Solutions Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
INBS
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Intelligent Bio Solutions Inc.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Harry Simeonidis
Headquarters
142 West 57th Street, New York City, NY, US
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Harry Simeonidis
Headquarters
142 West 57th Street, New York City, NY, US
Description

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News